Search

Introduction: A STOP-BANG questionnaire (SBQ) score of ≥3 may detect obstructive sleep apnea (OSA) but is not well studied in primary care (PC) Aims and Objectives: Assess the ability of SBQ to predict OSA severity in PC Methods: 30 to 70 year-olds attending any of 4 PC centres in a 22-month period were randomly selected. PC physician did the SBQ. A home respiratory polygraphy (HRP) was done when scores of ≥3 were found and an attended polysomnography (PSG) when apnea-hypopnea index (AHI) was Results: Of included patients (565), 38.2% had SBQ≥3. Of these, 93.1% were diagnosed with OSA (Figure 1). All cases with SBQ≥6 had an AHI≥5/h. SBQ discriminated patients with severe OSA (AHI≥30/h)(n=70, AUC=0.697, 95% CI:0.621-0.773): moderate in women (n=23, AUC=0.733, 95% CI:0.605-0.860) and lower in men (n=47, AUC=0.679, 95% CI:0.583-0.766). In these cases, SBQ≥5 in women had a sensitivity (Sn) of 52.2%, specificity (Sp) of 85.7%, positive likelihood ratio (LR+) of 3.65 and negative likelihood ratio (LR-) of 0.56; and SBQ≥6 in men gave Sn of 44.7%, Sp of 86.7%, LH+ of 3.35 and LH- of 0.64 Conclusions: SB≥3 may adequately screen for OSA in PC. Scores of SB≥5 in women and ≥6 in men could be good opportunistic predictors of severe OSA in PC.

Introduction: Diagnosing sleep apnoea syndrome (SAS) in hospital settings limits detection and is costly. We compare SAS diagnosis in primary care (PC) by respiratory polygraphy with automatic analysis (RPa) with currently validated methodology and hospital techniques. Material and methods: Random, cross-sectional, single-blind, multicentre study at four primary care centres and their reference hospital over 6 months. Patients between 30 and 70 years with high probability of SAS (STOP-BANG ≥3) who were visited at their primary care centre were included. Apnealink Air respiratory polygraphy was performed at home and read by the primary care doctor. Recorded data were sent online to the reference hospital and analysed manually by a sleep specialist. In patients with non-severe SAS (Apnoea-Hypopnoea Index Results: 76.2% (48/63) of patients completed the protocol; mean age 57.5±8.5; male sex 62.5%; BMI 30.5±5.8. 85.4% were diagnosed with RPa. Concordance between PC and hospital diagnosis was k=0.22 (Table 1). For severity, patients with SAS had a concordance of k=0.54 with a sensitivity of 45.4%; 95% CI (11.5-79.4), specificity of 100.0%; 95% CI (98.3-100.0), PPV 100.0% and NPV 83.3% (Table 2). Conclusion: RPa could be useful in diagnosing SAS in PC. Hospital diagnosis would not be needed in cases of severe SAS.

No placebo controlled clinical trials evaluating airway clearance techniques have been performed in BC. We evaluate short and long-term efficacy of ELTGOL in BC in a randomized control trial with placebo (Clinical Trial Registration NCT01578681). Non-cystic fibrosis BC adult patients in stable state with >10ml sputum/day not practising regular chest physiotherapy were randomized to perform ELTGOL or a placebo exercise twice daily. Patients were assessed at 7 visits (V) over one year. Primary endpoint: sputum volume during the procedure at V2 and 24-h post treatment. Secondary endpoints: sputum volume during the procedure at V7 and 24-h post treatment; Leicester Cough Questionnaire (LCQ), Saint George9s Respiratory Questionnaire (SGRQ). Results: 44 patients were randomized (22 ELTGOL group and 22 placebo group; mean age 63.04±13.48 and 67.72±9.08). Sputum volume during the procedure at V2 and 24-h post treatment were higher in the ELTGOL group (12.27±11.92ml vs. 0ml and 47.75±31.6ml vs. 12.04±9.86ml, p Conclusions: The ELTGOL technique is effective in airway clearance both in the short and long term, improves quality of life and reduces the impact of daily cough in non-cystic fibrosis BC adult patients. Funding: SEPAR, SOCAP, CFC, ACMG, Fiss PI12/01551.